AAV Challenges and Solutions
Webinar
Unlock the potential of AAV-based therapeutics while overcoming key development challenges. In this expert connect session, we explore strategies to optimize both upstream and downstream processes, accelerate time to clinic, and improve overall efficiency.
Learn how to enhance productivity, reduce cost of goods (COGS), and achieve scalable AAV manufacturing through proven process development approaches. Join us to gain practical insights into addressing the unique complexities of AAV and advancing your gene therapy programs faster.
In this expert connection session, you will learn:
- PD strategies for AAV
- Expedited time to clinic
- AAV Upstream Optimization
- Reduced COGS and improved yield
- AAV Downstream Process Development
- Improved scaleup for AAV manufacturing
Speakers
Janice Tan, Ph.D.
Merck
Head Upstream, Process Materials and Process Consultancy, APEC
Janice Tan heads the upstream, process materials and process consultancy team in Merck Asia Pacific excluding China. She and her team of scientists and engineers are responsible for providing technical consultation on upstream bioprocessing, bioprocess manufacturing optimization and troubleshooting. With over 23 years of experience in the biopharmaceutical industry, she has led multiple successful projects starting from cell line development to bioreactor scale-up by presenting holistic and innovative solutions to customers producing biotherapeutics. Janice received her Ph.D. in Biochemistry from the National University of Singapore.
Subhasis Banerjee, Ph.D.
Merck
Principal Process Consultant
Subhasis Banerjee is the Principal Process Consultant in Asia Pacific for Merck Life Sciences based out of Bangalore, India. Subhasis supports technical consultation for downstream processing for the APAC region. Previously he was heading the Manufacturing Sciences and Technology group; team of Scientists and Engineers for Singapore, South East Asia and Oceania supporting in optimizing downstream unit operations and providing scale up solutions to biological manufacturers. He is a Ph.D. in Biochemistry with a post-doctoral experience from The Ohio State University, Columbus, Ohio, USA. Dr. Banerjee has several publications in international peer reviewed journals and presentations in several national and International Conferences.
Moderator
Yosuke Imamura
Merck
Customer Application Novel Modality
Yosuke Imamura is a modality leader for viral vectors in the APeC region. With a strong emphasis on communication within APeC and with global teams, he actively identifies customer challenges and proposes tailored products and solutions. He is dedicated to enhancing the effectiveness of marketing activities, ensuring that clients are well informed about the latest advancements and applications in viral vector technology.
Gene Therapy Contract Development and Manufacturing
- Gene Therapy Formulation and Final Fill
期间:1h
语言:English
场次 1:Tue, June 30, 2026 2:00 PM SGT